BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28098902)

  • 1. Downregulation of leucine‑rich‑α‑2‑glycoprotein 1 expression is associated with the tumorigenesis of head and neck squamous cell carcinoma.
    Wang Y; Chen C; Hua Q; Wang L; Li F; Li M; Mei Z; Zhou T; Xiao B; Tao Z
    Oncol Rep; 2017 Mar; 37(3):1503-1510. PubMed ID: 28098902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.
    Schröck A; Bode M; Göke FJ; Bareiss PM; Schairer R; Wang H; Weichert W; Franzen A; Kirsten R; van Bremen T; Queisser A; Kristiansen G; Heasley L; Bootz F; Lengerke C; Perner S
    Carcinogenesis; 2014 Jul; 35(7):1636-42. PubMed ID: 24743512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.
    Liu CJ; Shen WG; Peng SY; Cheng HW; Kao SY; Lin SC; Chang KW
    Int J Cancer; 2014 Feb; 134(4):811-21. PubMed ID: 23824713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and Prognostic Relevance of GAGE1 and XAGE1 Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma.
    Karia BTR; Zamuner FT; Carlin V; de Oliveira CZ; Carvalho AL; Vettore AL
    Curr Mol Med; 2017; 17(10):707-717. PubMed ID: 29577858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Submaxillary Gland Androgen-regulated Protein 3A (SMR3A) in Adenoid Cystic Carcinoma of the Head and Neck.
    Thierauf J; Veit JA; Grünow J; Döscher J; Weißinger S; Whiteside T; Beutner D; Quaas A; Plinkert P; Hoffmann TK; Hess J
    Anticancer Res; 2016 Feb; 36(2):611-5. PubMed ID: 26851015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome.
    de Koning PJ; Bovenschen N; Leusink FK; Broekhuizen R; Quadir R; van Gemert JT; Hordijk GJ; Chang WS; van der Tweel I; Tilanus MG; Kummer JA
    Int J Cancer; 2009 Oct; 125(7):1542-50. PubMed ID: 19569240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
    Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
    Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
    Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
    J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent Krüppel-like factor 4 expression predicts progression and poor prognosis of head and neck squamous cell carcinoma.
    Tai SK; Yang MH; Chang SY; Chang YC; Li WY; Tsai TL; Wang YF; Chu PY; Hsieh SL
    Cancer Sci; 2011 Apr; 102(4):895-902. PubMed ID: 21219537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma.
    Cao W; Liu J; Xia R; Lin L; Wang X; Xiao M; Zhang C; Li J; Ji T; Chen W
    Oncotarget; 2016 Mar; 7(12):14537-50. PubMed ID: 26908444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Australian retrospective study to evaluate the prognostic role of p53 and eIF4E cancer markers in patients with head and neck squamous cell carcinoma (HNSCC): study protocol.
    Singh J; Jayaraj R; Baxi S; Mileva M; Curtin J; Thomas M
    Asian Pac J Cancer Prev; 2013; 14(8):4717-21. PubMed ID: 24083732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features.
    Rettig EM; Chung CH; Bishop JA; Howard JD; Sharma R; Li RJ; Douville C; Karchin R; Izumchenko E; Sidransky D; Koch W; Califano J; Agrawal N; Fakhry C
    Cancer Prev Res (Phila); 2015 Apr; 8(4):287-95. PubMed ID: 25633867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
    Clauditz TS; Wang CJ; Gontarewicz A; Blessmann M; Tennstedt P; Borgmann K; Tribius S; Sauter G; Dalchow C; Knecht R; Münscher A; Wilczak W
    J Oral Pathol Med; 2013 Feb; 42(2):125-32. PubMed ID: 22643116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of leucine-rich α2-glycoprotein-1 is a prognostic marker and enhances tumor migration in gastric cancer.
    Yamamoto M; Takahashi T; Serada S; Sugase T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Naka T; Mori M; Doki Y
    Cancer Sci; 2017 Oct; 108(10):2052-2060. PubMed ID: 28746773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implications.
    Carracedo DG; Astudillo A; Rodrigo JP; Suarez C; Gonzalez MV
    Oncol Rep; 2008 Sep; 20(3):589-95. PubMed ID: 18695910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis.
    Karahatay S; Thomas K; Koybasi S; Senkal CE; Elojeimy S; Liu X; Bielawski J; Day TA; Gillespie MB; Sinha D; Norris JS; Hannun YA; Ogretmen B
    Cancer Lett; 2007 Oct; 256(1):101-11. PubMed ID: 17619081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
    Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
    Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of endothelial progenitor cells (EPC) for tumorigenesis of head and neck squamous cell carcinoma (HNSCC): possible marker of tumor progression and neovascularization?
    Ziebart T; Blatt S; Günther C; Völxen N; Pabst A; Sagheb K; Kühl S; Lambrecht T
    Clin Oral Investig; 2016 Nov; 20(8):2293-2300. PubMed ID: 26993659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years.
    Blatt S; Voelxen N; Sagheb K; Pabst AM; Walenta S; Schroeder T; Mueller-Klieser W; Ziebart T
    Clin Oral Investig; 2016 Nov; 20(8):2097-2104. PubMed ID: 26728026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unknown primary of the head and neck: A long-term follow-up.
    Lanzer M; Bachna-Rotter S; Graupp M; Bredell M; Rücker M; Huber G; Reinisch S; Schumann P
    J Craniomaxillofac Surg; 2015 May; 43(4):574-9. PubMed ID: 25841309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.